查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424380

小容量注射劑的全球市場：按型態、按劑量類型、按包裝類型、按適應症類型、按最終用戶、按地區

Global Small Volume Parenteral Market, By Form, By Dose Type, By Packaging Type, By Indication Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2030 年，小容量注射劑的全球市場規模將從 2023 年的 1,796.2 億美元增至 2,985.7 億美元，預測期內年複合成長率（CAGR）為 7.5%。

報告範圍 報告詳情
基準年 2022年 2023/2024年市場規模 1796.2億美元
實際資料 2018-2021 預測期 2023-2030
預測期間 2023/2024 至 2030/2031 年複合年成長率： 7.50% 2030/2031價值預測 2985.7億美元
圖 1. 2023 年小容量注射製劑的全球市場佔有率（按地區分類）
全球小容量注射劑市場-IMG1

小容量注射藥物市場由注射劑量較小（通常小於 100 毫升）的注射藥物和製劑組成。小劑量注射製劑廣泛應用於治療糖尿病、癌症、感染疾病、鬱血性心臟衰竭等。靜脈注射、肌肉內、皮下和皮內給藥等途徑可以將藥物直接輸送到血液中。由於全球慢性和急性疾病的盛行率不斷增加，小容量注射劑市場正在穩步成長。此外，日益成長的老齡化人口容易受到多種健康狀況的影響，這推動了對易於小劑量給藥的藥物的需求。然而，注射劑生產的嚴格監管以及市場開拓的高成本可能會在一定程度上阻礙市場的擴張。

市場動態：

全球小容量注射藥物市場主要是由糖尿病、心血管疾病、癌症和呼吸系統疾病等慢性病盛行率上升所推動的。根據世界衛生組織（WHO）估計，2020年，慢性病將佔全球死亡人數的70%以上。此外，不斷成長的老年人口容易受到多種健康問題的影響，對小劑量胃腸外製劑的需求也隨之增加，以應對複雜的病理。此外，精確劑量、即時給藥和繞過胃腸道吸收等優點正在推動小容量腸胃外製劑的採用。然而，與注射藥物開發相關的高成本和注射藥物製造的嚴格法律規範繼續限制市場成長。同時，新型藥物輸送系統的進步預計將為相關人員提供有利可圖的機會。

本研究的主要特點

  • 本報告對全球小劑量注射藥物市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
  • 它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球小容量注射藥物市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 小容量注射劑全球市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球小容量注射藥物市場的各種策略矩陣，將促進相關人員的決策。

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場概況

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第 3 章 關鍵產業見解

  • 市場動態
  • 促進因素
  • 抑制因素
  • 機會
  • 影響分析
  • PEST分析
  • 波特的分析
  • 技術進步
  • 合併、收購和合作場景
  • 最近的產品核准/發布
  • 公司市場佔有率分析

第 4 章 小容量注射藥物市場，依型態，2018-2030

  • 液體
  • 烘乾

第5章小容量注射藥物市場，依劑量類型，2018-2030

  • 單一劑量
  • 多次給藥

第6章小容量注射藥物市場，依包裝類型，2018-2030

  • 安瓿
  • 管瓶
  • 預填充式注射器
  • 墨水匣
  • 瓶子
  • 其他

第7章小容量注射劑市場，依適應症類型，2018-2030

  • 疼痛管理
  • 癌症治療
  • 營養不良
  • 胃腸道疾病/腹瀉
  • 其他

第 8 章 小容量注射藥物市場，依最終使用者分類，2018-2030 年

  • 醫院
  • 診所
  • 門診手術中心年
  • 其他

第9章小容量注射劑市場，按地區，2018-2030

  • 按地區
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 中東和非洲
  • GCC
  • 以色列
  • 其他中東地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷

第10章公司簡介-小容量注射藥物市場

  • Fresenius Kabi AG
    • 公司簡介
    • 產品/服務組合
    • 財務績效
    • 最新動態/最新訊息
    • 策略概覽
  • Baxter
  • Sichuan Kelun
  • BML Parenteral Drugs
  • ICU Medical, Inc.
  • Pfizer Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • WuXi AppTec
  • Akums Drugs & Pharmaceuticals Ltd.
  • Orion Corporation
  • Rusoma Laboratories Private Limited
  • Higgs Healthcare
  • Syntegon Technology GmbH

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI6522

Global small volume parenteral market size is expected to reach US$ 298.57 Bn by 2030, from US$ 179.62 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 7.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 179.62 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 7.50% 2030/2031 Value Projection: US$ 298.57 Bn
Figure 1. Global Small Volume Parenteral Market Share (%), By Region, 2023
Global Small Volume Parenteral Market - IMG1

The small volume parenteral market consists of parenteral drugs and formulations administered in small volumes usually less than 100 milliliter. Small volume parenteral find widespread application in treating conditions such as diabetes, cancer, infections, and congestive heart failures. They aid in delivering medications directly into the bloodstream through routes such as intravenous, intramuscular, subcutaneous, and intradermal delivery. The small volume parenteral formulations market has been witnessing steady growth driven by the growing prevalence of chronic and acute diseases worldwide. Moreover, the rising geriatric population prone to multiple health conditions has boosted the demand for easily administrable drugs in mini doses. However, stringent regulations for manufacturing parenteral drugs and high costs that are associated with drug development may impede the market expansion to some extent.

Market Dynamics:

Global small volume parenteral market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, cancer, and respiratory diseases. As per the estimates of World Health Organization (WHO), chronic diseases accounted for over 70% of all deaths worldwide in 2020. Growing geriatric population base which is also susceptible to multiple health issues, has intensified the demand for small volume parenteral formulations to manage complex conditions. Furthermore, advantages such as precise dosing, immediate delivery of medication, and bypassing gastrointestinal absorption have augmented the adoption of small volume parenteral. However, high costs associated with parenteral drug development and stringent regulatory framework for manufacturing injectable drugs continues to restrict the market growth. On the other hand, ongoing advancements in novel drug delivery systems are expected to unleash lucrative opportunities for stakeholders.

Key features of the study:

  • This report provides in-depth analysis of the global small volume parenteral market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global small volume parenteral market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Fresenius Kabi AG, Baxter, Sichuan Kelun, BML Parenteral Drugs, ICU Medical, Inc., Pfizer Inc., Becton Dickinson and Company, B. Braun Melsungen AG, WuXi AppTec , Akums Drugs & Pharmaceuticals Ltd., Orion Corporation, Rusoma Laboratories Private Limited, Higgs Healthcare and Syntegon Technology GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global small volume parenteral market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small volume parenteral market

Detailed Segmentation:

  • Global Small Volume Parenteral Market, By Form
    • Liquid
    • Dry
  • Global Small Volume Parenteral Market, By Dosage Type
    • Single-dose
    • Multiple-dose
  • Global Small Volume Parenteral Market, By Packaging Type
    • Ampoules
    • Vials
    • Pre-filled Syringes
    • Cartridges
    • Bottles
    • Others
  • Global Small Volume Parenteral Market, By Indication Type
    • Pain Management
    • Cancer Care
    • Malnourishment
    • Gastrointestinal disorder/Diarrhea
    • Diabetes
    • Others
  • Global Small Volume Parenteral Market, By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Small Volume Parenteral Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global Small Volume Parenteral Market:
    • Fresenius Kabi AG
    • Baxter
    • Sichuan Kelun
    • BML Parenteral Drugs
    • ICU Medical, Inc.
    • Pfizer Inc.
    • Becton Dickinson and Company
    • Braun Melsungen AG
    • WuXi AppTec
    • Akums Drugs & Pharmaceuticals Ltd.
    • Orion Corporation
    • Rusoma Laboratories Private Limited
    • Higgs Healthcare
    • Syntegon Technology GmbH

Table of Content

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Top 3 Market Findings
    • Top 3 Market Opportunity

3. Key Industry Insights

  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals/Launches
  • Company Market Share Analysis

4. Small Volume Parenteral Market, By Form, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Liquid, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Dry, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

5. Small Volume Parenteral Market, By Dose Type, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Single-dose, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Multiple-dose, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

6. Small Volume Parenteral Market, By Packaging Type, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Ampoules, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Vials, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Pre-filled Syringes, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Cartridges, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Bottles, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Others, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

7. Small Volume Parenteral Market, By Indication Type, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Share Analysis, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Pain Management
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Cancer Care, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Malnourishment, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Gastrointestinal Disorder/diarrhea, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Diabetes, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Others, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

8. Small Volume Parenteral Market, By End User, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Hospitals, 2018 - 2030( US$ Billion)
  • Clinics, 2018 - 2030( US$ Billion)
  • Ambulatory Surgical Centers, 2018 - 2030( US$ Billion)
  • Others, 2018 - 2030( US$ Billion)

9. Small Volume Parenteral Market, By Region, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • By Region
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • North America
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest Of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • GCC
  • Israel
  • Rest Of Middle East
  • Latin America
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • Brazil
  • Mexico
  • Argentina

10. Company Profiles - Small Volume Parenteral Market

  • Fresenius Kabi AG*
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
  • Strategic Overview
  • Baxter
  • Sichuan Kelun
  • BML Parenteral Drugs
  • ICU Medical, Inc.
  • Pfizer Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • WuXi AppTec
  • Akums Drugs & Pharmaceuticals Ltd.
  • Orion Corporation
  • Rusoma Laboratories Private Limited
  • Higgs Healthcare
  • Syntegon Technology GmbH

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact